Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-17
1989-04-11
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546283, C07D40100, A61K 3144
Patent
active
048207187
ABSTRACT:
The invention discloses certain N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts useful as PAF inhibitors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method of using such compositions for inhibiting PAF-induced blood platelet aggregation, PAF-mediated bronchoconstriction and extravasation, PAF-induced hypotension, PAF-induced ischemic bowel disease and PAF-mediated, endotoxin-induced lung injury.
REFERENCES:
patent: 4711892 (1987-12-01), Manoury et al.
Borovian Joseph J.
Honor Robert S.
Lee Mary C.
Sandoz Pharm. Corp.
Sharkin Gerald D.
LandOfFree
N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furany does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furany, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furany will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-667485